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INTRODUCTION
Many progressive neurodegenerative
diseases including Huntington’s dis-
ease, spinobulbar muscular atrophy,
dentatorubral pallidoluysian atrophy,
and spinocerebellar ataxia types 1, 2,
3, 6, and 7 are caused by an expansion
of CAG (polyglutamine) codons at the
ends of genes coding for various pro-
teins (reviewed in, e.g., Reddy and
Housman, 1997). In every case except
the type 6 ataxia, which involves a
defective calcium channel (Lunkes and
Mandel, 1997), expansions of up to
about 35 residues are benign, whereas
expansions of 40 residues are patho-
genic. Perutz (1999) has hypothesized
that sufficiently long glutamine repeats
can form hairpin structures that desta-
bilize proteins and produce insoluble
aggregates. The presence of protein
aggregates inside afflicted neurons is,
in fact, a post-mortem diagnostic
marker of these diseases (Lunkes et al.,
1998). However, it is not known
whether the aggregates themselves are
pathogenic or are, instead, by-products
of other cellular processes. Recent
work with yeast, for example, has
shown that aggregated fragments of
polyglutamine-expanded huntingtin
protein, the causative factor in Hun-
tington’s disease, are not particularly
toxic to cells expressing them (Kro-
bitsch and Lindquist, 2000). Also, Sau-
dou et al. (1998) found that inhibiting
ubiquination and consequent forma-
tion of aggregates in the cell nucleus
increased rather than decreased the
toxic effect of polyglutamine-ex-
panded huntingtin expressed in trans-
fected striatal neurons. Although the
evidence linking glutamine expansion
length with both disease and protein
aggregates is clear and abundant, a
mechanistic relationship between pro-
tein aggregation and cellular toxicity
has yet to be established. In this issue
of the Biophysical Journal, Monoi et
al. (2000) provide evidence in support
of a strikingly simple and direct alter-
native to the aggregation hypothesis to
explain the length dependence of poly-
glutamine toxicity: only repeats greater
than 40 residues are long enough to
form membrane-depolarizing ion chan-
nels in cells.
At the heart of this hypothesis is a
novel protein structure, the -helix,
predicted to be stable only for polyglu-
tamine sequences (Monoi, 1995). This
structure is remarkable in that a single,
all L-amino acid polypeptide chain
forms a helix with a 3.7 Å diameter
cylindrical pore along its axis, physi-
cally large enough to accommodate
passage of small ions and water. In the
helix, each residue adds only about
0.81 Å to the length, so spanning 30 Å
of bilayer hydrocarbon requires at least
37 residues instead of the 20 required
for an -helix. The interior of the pore
is lined with backbone amide and car-
bonyl groups, much like gramicidin.
The exterior surface of the pore is
made up of glutamine side chains
whose amide carbonyls form hydrogen
bonds to side chain amide NH2 groups
6 residues away toward the peptide’s
amino terminus. These hydrogen
bonds, together with those of the op-
positely directed backbone amide hy-
drogen bonds, presumably provide suf-
ficient energy to stabilize an otherwise
energetically improbable structure. Or-
dinarily, one might dismiss the sugges-
tion that an ion channel structure has
polar glutamine residues exposed to
bilayer hydrocarbon. However, Monoi
et al. (2000) point out that the hydro-
gen bonding of glutamine’s side chain
amides significantly reduces their un-
favorable free energy of transfer to the
hydrocarbon, so bilayer insertion is not
implausible.
Given that such a structure, albeit
never observed in protein solution or
crystal structures, is possible, Monoi
and coworkers then set about to deter-
mine experimentally if polyglutamine
could make ion channels. Because
polyglutamine peptides are virtually
impossible to purify to homogeneity,
the authors compared two samples that
had been prepared and partially puri-
fied in the same way, but which con-
tained peptides of 29 versus 40 resi-
dues maximum length. Only the
sample containing the longer peptides
made ion channels in multiple, well-
controlled planar bilayer experiments.
Moreover, the observed channels had
the well-defined unit conductances
characteristic of stable ion channel
structures, rather than the erratic con-
ductance fluctuations often observed
with membrane-perturbing protein
fragments and peptide toxins such as
melittin. Strikingly, the channels were
small, cation-selective, and only very
weakly rectifying, all properties one
might predict from the -helix structure.
Where might this work lead? Cer-
tainly, it should inspire efforts to make
and characterize -helix structures in
smaller, soluble polyglutamine pep-
tides (see, e.g., Perutz et al., 1994), as
well as to confirm and extend the
present ion channel study to a wider
range of glutamine repeat lengths. In
addition, there are many questions to
be answered about how polyglutamine
repeats might produce cell-specific
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toxic effects in vivo. Does insolubility
precede, parallel, or follow ion channel
formation? Could it be that certain
membrane lipid compositions are more
susceptible than others, similar to the
tropism observed with some natural
peptide toxins? Are other proteins in-
volved in the process? Might these
small, probably sparse channels cause
slow neuronal death by chronically
overtaxing already highly active ATP-
dependent ion pumps?
The challenge of biophysics has al-
ways been to find, in the complex pro-
cesses observed in living systems, rel-
atively simple underlying physical
mechanisms. This class of devastating,
incurable illnesses presents this chal-
lenge in the very urgent context of
human medicine, and Monoi and co-
workers are to be commended for a
creative and inventive effort in ad-
dressing it.
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